LEF1 Antikörper (AA 256-297)
Kurzübersicht für LEF1 Antikörper (AA 256-297) (ABIN187662)
Target
Alle LEF1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 256-297
-
Spezifität
- This antibody detects all isoforms of LEF-1 by Western blot. Does not crossreact with TCF-1 or TCF-4. Species Reactivity: Human. Others not tested.
-
Sterilität
- 0.2 μm filtered
-
Immunogen
- Recombinant full length LEF-1 protein.
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
- Western blot The optimal dilution for a specific application should be determined by the researcher.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Buffer
- Purified antibody 100 µg at 1.0 mg/mL. Provided as 0.2 µm sterile filtered solution in phosphate buffered saline with 0.08% sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
-
- LEF1 (Lymphoid Enhancer-Binding Factor 1 (LEF1))
-
Andere Bezeichnung
- LEF1
-
Hintergrund
- Lymphoid Enhancer Factor-1 (LEF-1) is an HMG 1/2-like DNA binding/bending protein and is a member of the LEF/TCF transcription factor family. There are four LEF/TCF family members in mammalian systems (LEF-1, TCF-1, TCF-3 and TCF-4), and orthologs to these factors have been identified in many different species. LEF/TCFs are downstream mediators of Wnt/Wingless signals. Wnt signaling drives cell polarity, cell fate and cell growth decisions in embryonic tissues and in post-natal tissues that continue to develop from mitotically active stem cell precursors. Misregulation of Wnt signaling is also implicated as a root cause of many different cancers, such as colon cancer, melanoma, breast cancer, prostate cancer and others.
-
Pathways
- WNT Signalweg, Intracellular Steroid Hormone Receptor Signaling Pathway, Regulation of Hormone Metabolic Process, Nuclear Hormone Receptor Binding, Chromatin Binding
Target
-